Oral Doxycycline for Acne in a 2026 Systematic Review: How Adults With Persistent Acne Can Avoid Overreading the Headline

The 2026 systematic review does not show oral doxycycline beats other acne therapies. Adults with persistent acne should read it as evidence of similar results with important limits, not as a new reason to seek doxycycline alone. Acne vulgaris means common acne with blackheads, pimples, and tender red bumps. Doxycycline is an oral antibiotic that fights acne-linked bacteria and inflammation, while a systematic review pools prior trials to compare treatments.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

What did the 2026 review cover?
Did doxycycline reduce lesions better?
Where did the headline break down?
What safety and resistance limits apply?
What should adults with persistent acne do next?

What did the 2026 review cover?

The review compared oral doxycycline with other acne therapies following PRISMA guidelines. PubMed/NIH lists it as published March 17, 2026, pooling 23 randomized trials with 2,672 patients, described in the PubMed/NIH record.

That design makes the review broad, but broad does not mean final. The included trials differed in drugs, doses, and measures, so adult readers should look past the headline to specific outcomes.

Did doxycycline reduce lesions better?

No. Treatment success was similar for doxycycline and azithromycin, with odds ratio 1.28, 95 percent CI 0.54 to 3.04, p equals 0.57, and moderate heterogeneity I2 equals 60 percent.

Inflammatory lesion-count change also showed no significant difference, mean difference minus 0.71, 95 percent CI minus 8.61 to 7.19, p equals 0.86. In plain terms, some patients improved on each drug, but the pooled gap favored neither drug. High variation across trials adds more reason not to treat near-equal averages as proof of superiority.

Where did the headline break down?

Global Acne Grading System scores favored control treatments over doxycycline. PubMed Central/NIH reports mean difference 1.76, 95 percent CI 1.53 to 2.00, p less than 0.00001, detailed in the full review on PubMed Central/NIH.

That result matters because grading scores capture extent and severity across face, chest, and back. A drug can look similar on one count and still score worse on overall severity.

What safety and resistance limits apply?

U.S. prescribing information warns doxycycline can cause sun sensitivity, throat pain or ulcer, permanent tooth color change when used in pregnancy or childhood, and pressure around the brain that requires stopping the drug, per the DailyMed/NLM label.

Take it upright with a full glass of water, use daily sun protection, and report severe headache, vision change, chest pain, or trouble swallowing promptly. To curb resistance, guidelines advise limiting oral antibiotics to 3 to 4 months, avoiding oral or topical antibiotic monotherapy, and always pairing treatment with benzoyl peroxide or a retinoid, according to the Infectious Disease Advisor summary of AAD and European guidelines. That combination approach matters more than the brand of antibiotic alone.

What should adults with persistent acne do next?

Persistent adult acne is common. Healio reporting a University of Pennsylvania dermatology study notes about 50 percent of women in their 20s and about 35 percent in their 30s have acne, so treatment choices often extend well past the teen years. Bring the review to a visit as a starting point, not a prescription request:.

Ask what outcome matters for your acne: fewer tender bumps, lower severity score, or faster clearing.
Ask how long an oral antibiotic would run, what it would pair with, and when you would stop or switch.
Report pregnancy plans, sun exposure, swallowing problems, headache, and vision changes before starting doxycycline.